Transcriptional instability during evolving sepsis may limit biomarker based risk stratification
Antonia Kwan, Mike Hubank, Asrar Rashid, Nigel Klein, Mark J Peters, Antonia Kwan, Mike Hubank, Asrar Rashid, Nigel Klein, Mark J Peters
Abstract
Background: Sepsis causes extensive morbidity and mortality in children worldwide. Prompt recognition and timely treatment of sepsis is critical in reducing morbidity and mortality. Genomic approaches are used to discover novel pathways, therapeutic targets and biomarkers. These may facilitate diagnosis and risk stratification to tailor treatment strategies.
Objective: To investigate the temporal gene expression during the evolution of sepsis induced multi-organ failure in response to a single organism, Neisseria meningitidis, in previously healthy children.
Method: RNA was extracted from serial blood samples (6 time points over 48 hours from presentation) from five critically ill children with meningococcal sepsis. Extracted RNA was hybridized to Affymetrix arrays. The RNA underwent strict quality control and standardized quantitation. Gene expression results were analyzed using GeneSpring software and Ingenuity Pathway Analysis.
Result: A marked variability in differential gene expression was observed between time points and between patients revealing dynamic expression changes during the evolution of sepsis. While there was evidence of time-dependent changes in expected gene networks including those involving immune responses and inflammatory pathways, temporal variation was also evident in specific "biomarkers" that have been proposed for diagnostic and risk stratification functions. The extent and nature of this variability was not readily explained by clinical phenotype.
Conclusion: This is the first study of its kind detailing extensive expression changes in children during the evolution of sepsis. This highlights a limitation of static or single time point biomarker estimation. Serial estimations or more comprehensive network approaches may be required to optimize risk stratification in complex, time-critical conditions such as evolving sepsis.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM (2001) Meningococcal disease. N Engl J Med 344: 1378–1388.
- Angus DC (2011) The search for effective therapy for sepsis: back to the drawing board? JAMA 306: 2614–2615.
- Stephens DS, Greenwood B, Brandtzaeg P (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196–2210.
- Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, et al. (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166: 1197–1205.
- Bion J (2012) Surviving sepsis: a systems issue. Lancet Infect Dis 12: 898–899.
- Booy R, Habibi P, Nadel S, de Munter C, Britto J, et al. (2001) Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 85: 386–390.
- Peters MJ, Ross-Russell RI, White D, Kerr SJ, Eaton FE, et al. (2001) Early severe neutropenia and thrombocytopenia identifies the highest risk cases of severe meningococcal disease. Pediatr Crit Care Med 2: 225–231.
- Deasy A, Read RC (2010) Genetic variation in pro-inflammatory cytokines and meningococcal sepsis. Curr Opin Infect Dis 23: 255–258.
- Wong HR, Wheeler DS, Tegtmeyer K, Poynter SE, Kaplan JM, et al. (2010) Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med 38: 1955–1961.
- Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, et al. (2009) Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37: 1558–1566.
- Osuchowski MF, Connett J, Welch K, Granger J, Remick DG (2009) Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 37: 1567–1573.
- Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, et al. (2007) Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 30: 146–155.
- Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, et al. (2007) Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 13: 495–508.
- Cornell TT, Wynn J, Shanley TP, Wheeler DS, Wong HR (2010) Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 125: 1248–1258.
- Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032–1037.
- Tibby SM, Murdoch IA, Durward A (2002) Mortality in meningococcal disease: please report the figures accurately. Arch Dis Child 87: 559–author reply 560.
- Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, et al. (2000) Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356: 961–967.
- Solan PD, Dunsmore KE, Denenberg AG, Odoms K, Zingarelli B, et al. (2012) A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 40: 379–387.
Source: PubMed